The Next Big One

As new infections surface and spread, science meets the challenges with ingenuity and adaptation.

Written byMary Beth Aberlin
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

© ACE_CREATE/ISTOCKPHOTO.COMThese days, warnings of worldwide infection seem like monthly occurrences. And they’re not just in the popular press, but in scientific journals and in bulletins from public-health organizations. Think how many times in the last few years we have been told that a new global pandemic is at least possible, if not imminent—warnings fueled by reports of a newly emerging, particularly deadly virus, or a known pathogen accruing some dangerous new mutation. Think of the controversy that raged last year over whether to allow the publication of papers from two laboratories describing the experimental creation of mutated versions of the highly virulent but not easily spread H5N1 avian influenza virus—strains that were more transmissible between mammals. Warnings rang out about possible pandemics should the lab-mutated viruses accidently escape, and about terrorists using information gleaned from the scientific publications to create biological weapons.

This year’s flu season saw the arrival of yet another new and confounding influenza strain, H7N9, rare and so far not easily transmitted between humans, but especially deadly, at least at first glance. And, on May 12, as The Scientist goes to press, the World Health Organization issued a global alert about yet another highly virulent organism, this time a novel coronavirus—the same type of virus responsible for the SARS epidemic of 2002–2003—which first appeared in Saudi Arabia in September 2012 and is responsible to date for a total of 40 laboratory-confirmed cases of human infection, including 20 deaths. When the infection was first reported, it stoked fears that the enormous number of Muslims gathered in Mecca for the annual October pilgrimage would be a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies